Ironwood Pharmaceuticals Affirms FY2026 Sales Guidance of $450.000M-$475.000M
Benzinga Newsdesk 8 months ago
NewsGuidance
Ironwood Pharmaceuticals (NASDAQ:IRWD) affirms FY2026 sales outlook from $450.000 million-$475.000 million to $450.000 million-$475.000 million.
Ironwood Pharmaceuticals (NASDAQ:IRWD) affirms FY2026 sales outlook from $450.000 million-$475.000 million to $450.000 million-$475.000 million.